ApoE, Alzheimer's Disease, and Recovery from Brain Stress a

ABSTRACT: Apolipoprotein E (APOE, gene; ApoE, protein) is the major genetic susceptibility locus for the common forms of Alzheimer's disease (AD). There are three common polymorphisms in the population: ɛ2, ɛ3, and ɛ4. The inheritance of each dose of ɛ4 increases the risk and lowers the age of onset distribution for AD; ɛ2 lowers the risk and increases the age of onset distribution. APOE‐ɛ4 has a high positive predictive value for AD, and is clinically useful as an adjunct in the early diagnosis of cognitively impaired patients. The APOE alleles have also been associated with risk of AD with head injury, intraneuronal localization of ApoE in animal stroke models, recovery of function after intracerebral hemorrhage, and recovery of psychological parameters after general cardiac anesthesia. A multifunctional role of ApoE in the brain implicates isoform‐specific differences in interactions with several brain proteins including Añ, tau, and MAP‐2. Intraneuronal ApoE is increased temporally and in relevant neurons in AD as a function of APOE genotype. Decreased glucose metabolism can be demonstrated by PET imaging in subjects two decades before the median age of onset as a function of APOE genotype. ApoE isoforms may also have different effects as antioxidants. The risk of stroke and vascular dementia has not been confirmed in neuropathological series to be related to specific APOE genotypes.

[1]  S. Young,et al.  Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. , 1991, The Journal of clinical investigation.

[2]  A. Haase,et al.  Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes , 1991, Journal of virology.

[3]  D. Hedley,et al.  Flow cytometric measurement of lipid peroxidation in vital cells using parinaric acid. , 1992, Cytometry.

[4]  E. Stadtman.  Protein oxidation and aging , 2006, Science.

[5]  N. Maeda,et al.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.

[6]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[7]  S. Vandenberg,et al.  Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. , 1992, The American journal of pathology.

[8]  S. Gauthier,et al.  Apolipoprotein E polymorphism and Alzheimer's disease , 1993, The Lancet.

[9]  S. Gauthier,et al.  Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats , 1993, Neuroscience.

[10]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  B. Hyman,et al.  Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.

[12]  A D Roses,et al.  Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[14]  M A Pericak-Vance,et al.  Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. , 1993, Neurology.

[15]  A. Roses,et al.  Apolipoprotein E Is Localized to the Cytoplasm of Human Cortical Neurons: A Light and Electron Microscopic Study , 1994, Journal of neuropathology and experimental neurology.

[16]  M. Pericak-Vance,et al.  Apolipoprotein E Is Present in Hippocampal Neurons without Neurofibrillary Tangles in Alzheimer's Disease and in Age-Matched Controls , 1994, Experimental Neurology.

[17]  M. Pericak-Vance,et al.  Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[19]  L. Murray,et al.  Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[20]  M. Pericak-Vance,et al.  Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease , 1994, Neuroscience Letters.

[21]  Margaret A. Pericak-Vance,et al.  Hypothesis: Microtubule Instability and Paired Helical Filament Formation in the Alzheimer Disease Brain Are Related to Apolipoprotein E Genotype , 1994, Experimental Neurology.

[22]  P. Froguel,et al.  Genetic associations with human longevity at the APOE and ACE loci , 1994, Nature Genetics.

[23]  P A Wolf,et al.  Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. , 1994, JAMA.

[24]  D. Arveiler,et al.  Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[25]  J. Hardy,et al.  ApoE genotype and Down's syndrome , 1994, The Lancet.

[26]  A. Roses.  On the metabolism of apolipoprotein E and the Alzheimer diseases , 1995, Experimental Neurology.

[27]  D. Graham,et al.  Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury , 1995, Nature Medicine.

[28]  J. Breslow,et al.  Apolipoprotein E and the apolipoprotein E-deficient mouse. , 1995, Annual review of nutrition.

[29]  B. Yankner,et al.  Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro , 1995, Nature.

[30]  J. Dietschy,et al.  Sterol metabolism in fetal, newborn, and suckled lambs and their response to cholesterol after weaning. , 1995, The American journal of physiology.

[31]  D. Michaelson,et al.  Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice , 1995, Neuroscience Letters.

[32]  A. Roses,et al.  Head injury, amyloid β and Alzheimer's disease , 1995, Nature Medicine.

[33]  W. Strittmatter,et al.  ApoE genotype and survival from intracerebral haemorrhage , 1995, The Lancet.

[34]  W. White,et al.  Predictors of cognitive decline after cardiac operation. , 1995, The Annals of thoracic surgery.

[35]  A. Roses,et al.  Neurodegeneration in the Central Nervous System of apoE-Deficient Mice , 1995, Experimental Neurology.

[36]  D. Graham,et al.  Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. , 1995, Nature medicine.

[37]  B. Tycko,et al.  Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease , 1995, Neurology.

[38]  J. Stengård,et al.  Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. , 1995, Circulation.

[39]  W. Benzing,et al.  Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to tau and PHF in Alzheimer's disease , 1995, Experimental Neurology.

[40]  J. Merikangas.  The Molecular and Genetic Basis of Neurological Disease , 1995 .

[41]  B. Hyman,et al.  Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype. , 1995, Archives of neurology.

[42]  J. Poirier,et al.  Apolipoprotein E and Low‐Density Lipoprotein Binding and Internalization in Primary Cultures of Rat Astrocytes: Isoform‐Specific Alterations , 1996, Journal of neurochemistry.

[43]  A. Roses.  From genes to mechanisms to therapies: Lessons to be learned from neurological disorders , 1996, Nature Medicine.

[44]  Bradley T. Hyman,et al.  Apolipoprotein E ε4 Is Associated With the Presence and Earlier Onset of Hemorrhage in Cerebral Amyloid Angiopathy , 1996 .

[45]  T. Montine,et al.  E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. , 1996, The American journal of pathology.

[46]  D. Graham,et al.  High frequency of apolipoprotein E epsilon 2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. , 1996, Annals of neurology.

[47]  D. Graham,et al.  High frequency of apolipoprotein E ε2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy , 1996 .

[48]  J. Gilbert,et al.  Human Apolipoprotein E2, E3, and E4 Isoform-Specific Transgenic Mice: Human-like Pattern of GlialandNeuronal Immunoreactivity in Central Nervous System Not Observed in Wild-Type Mice , 1996, Neurobiology of Disease.

[49]  J. Poirier,et al.  Apolipoprotein E, Plaques, Tangles and Cholinergic Dysfunction in Alzheimer's Disease a , 1996, Annals of the New York Academy of Sciences.

[50]  T. Montine,et al.  Crosslinking of Apolipoprotein E by Products of Lipid Peroxidation , 1996, Journal of neuropathology and experimental neurology.

[51]  B T Hyman,et al.  Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. , 1996, Stroke.

[52]  D. Michaelson,et al.  Derangement in stress response of apolipoprotein E-deficient mice , 1996, Neuroscience Letters.

[53]  A D Roses,et al.  Apolipoprotein E alleles as risk factors in Alzheimer's disease. , 1996, Annual review of medicine.

[54]  A. Takahashi,et al.  Cystatin C and apolipoprotein E immunoreactivities in CA1 neurons in ischemic gerbil hippocampus , 1996, Brain Research.

[55]  K. Horsburgh,et al.  Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the rat , 1996, Neuropathology and applied neurobiology.

[56]  B. Dastugue,et al.  [Apolipoprotein E and Alzheimer's disease]. , 1998, Annales de biologie clinique.